ETHYPHARM

HALL, Saint-Cloud, Île-de-France, France

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

66.7%

Trial Status Distribution

Completed

66.7%

Recruiting

33.3%

Clinical Trials

Trials sponsored by this organization (3)

Baclocur® Post-Authorisation Safety Study in Real-life Settings in France

Recruiting

observational

Dec 2020975 participants

Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients

Phase 3

Completed

interventional

Dec 2012316 participants

Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer

Phase 3

Completed

interventional

Nov 201191 participants

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

SFDA

Saudi Food and Drug Authority

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

Approvals

Recent Approvals

EP-Feno tablet 145 mg

NPRA

2026-03-27

Lorpitan Trio (Aprepitant 125mg Hard Capsule)

NPRA

2025-11-28

Lorpitan Trio (Aprepitant 80mg Hard Capsule)

NPRA

2025-11-28

Fenofibrate Ethypharm

MORFINA ETHYPHARM 20 MG/ML SOLUCION INYECTABLE

CIMA_AEMPS

2019-11-25

MORFINA ETHYPHARM 10 MG/ML SOLUCION INYECTABLE EFG

CIMA_AEMPS

2019-11-25

LINEVERO 10 MG COMPRIMIDOS EFG

CIMA_AEMPS

2019-09-19

News

No news articles found

Back to Organizations